[Epidermolysis bullosa herpetiformis of Dowling-Meara].
Larrègue
M
M
Service de Dermatologie, Hôpital de la Miletrie, Poitier.
Bressieux
J M
JM
Fusade
T
T
Matard
B
B
Crampon
P
P
Salhi
A
A
D002648:Child; D002921:Cicatrix / Q000473:pathology; D016110:Epidermolysis Bullosa Simplex / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D015603:Keratinocytes / Q000648:ultrastructure; D007645:Keratoderma, Palmoplantar / Q000150:complications; D008297:Male; D009260:Nail Diseases / Q000150:complications; D010672:Phenytoin / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D014810:Vitamin E; D010672:Phenytoin
Epidermolyse bulleuse herpétiforme de Dowling Meara (EBHDM).